Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
PhaseBio Cleared by FDA for Trial of Virus Treatment
By Tony Owusu
May 28, 2020 10:00 AM EDT
PRESS RELEASES
PhaseBio Provides Pemziviptadil (PB1046) Program Update
By Business Wire
Oct 23, 2020 8:00 AM EDT
PRESS RELEASES
PhaseBio To Present At The H.C. Wainwright 22nd Annual Global Investment Conference
By Business Wire
Sep 9, 2020 4:05 PM EDT
PRESS RELEASES
PhaseBio To Present At The William Blair Biotech Focus Conference 2020
By Business Wire
Aug 3, 2020 4:01 PM EDT
PRESS RELEASES
PhaseBio Doses First Patient In VANGARD Phase 2 Clinical Trial To Evaluate PB1046 For Hospitalized COVID-19 Patients
By Business Wire
Jul 16, 2020 4:05 PM EDT
INVESTING
PhaseBio Cleared by FDA for Trial of Virus Treatment
By Tony Owusu
May 28, 2020 10:00 AM EDT
PRESS RELEASES
PhaseBio Launches Clinical Trial To Evaluate PB1046 As A Treatment For Hospitalized COVID-19 Patients
By Business Wire
May 27, 2020 4:01 PM EDT
